Fujita Health University · Faculty of Medicine / Graduate School of Medicine · 講師

Research keywordsautosomal dominant polycystic kidney disease・SGLT2 inhibitors・hemodialysis outcomes・renal fibrosis・mesenchymal stem cell renoprotection・vascular access

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Meflin is a marker of pancreatic stellate cells involved in fibrosis and epithelial regeneration in the pancreas
• Dapagliflozin use in tolvaptan-treated patients with ADPKD: exploring renal outcomes in a retrospective study
• A novel renal perivascular mesenchymal cell subset gives rise to fibroblasts distinct from classic myofibroblasts
• The Type of Vascular Access and the Incidence of Mortality in Japanese Dialysis Patients

• Official profile